Schwemmlein, Julia
Maack, Christoph
Bertero, Edoardo
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Accepted: 12 January 2022
First Online: 11 February 2022
Declarations
:
: Dr Maack reports personal fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Berlin Chemie, Novartis, Amgen, Servier, and Novo Nordisk, outside the submitted work. Dr Schwemmlein and Dr Bertero declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.